About The Study: This study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines investigated cases and incidence of Guillain-Barré syndrome (GBS) following vaccination and assessed the risk of GBS after vaccination with the Janssen, Pfizer-BioNTech or Moderna COVID-19 vaccines.
Authors: Nicola P. Klein, M.D., Ph.D., of Kaiser Permanente Northern California in Oakland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.8879)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.8879?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042622
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open